Clinical Trial Update: Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Levodopa/Carbidopa/Entacapone to Levodopa/Carbidopa in Parkinson's disease patients with early wearing-off; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SINEMET (carbidopa and levodopa)
• Stalevo (levodopa;carbidopa;entacapone)

Snippet

Sponsor: Novartis | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2011-03-15